vs
ETHAN ALLEN INTERIORS INC（ETD）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
ETHAN ALLEN INTERIORS INC的季度营收约是再鼎医药的1.1倍（$135.8M vs $127.1M），再鼎医药同比增速更快（17.1% vs -4.8%），过去两年再鼎医药的营收复合增速更高（20.8% vs -10.2%）
伊森艾伦内饰公司是美国家居家具制造商与零售商，公司注册于特拉华州，总部行政办公室位于康涅狄格州丹伯里。截至2023年6月30日，该公司年度净销售额达7.914亿美元。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
ETD vs ZLAB — 直观对比
营收规模更大
ETD
是对方的1.1倍
$127.1M
营收增速更快
ZLAB
高出21.9%
-4.8%
两年增速更快
ZLAB
近两年复合增速
-10.2%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $135.8M | $127.1M |
| 净利润 | $5.9M | — |
| 毛利率 | 59.4% | 51.0% |
| 营业利润率 | 4.8% | -54.6% |
| 净利率 | 4.4% | — |
| 营收同比 | -4.8% | 17.1% |
| 净利润同比 | -38.2% | — |
| 每股收益（稀释后） | $0.23 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ETDZLAB
| Q1 26 | $135.8M | — | ||
| Q4 25 | $149.9M | $127.1M | ||
| Q3 25 | $147.0M | $115.4M | ||
| Q2 25 | $160.4M | $109.1M | ||
| Q1 25 | $142.7M | $105.7M | ||
| Q4 24 | $157.3M | $108.5M | ||
| Q3 24 | $154.3M | $101.8M | ||
| Q2 24 | $168.6M | $100.1M |
净利润ETDZLAB
| Q1 26 | $5.9M | — | ||
| Q4 25 | $11.7M | — | ||
| Q3 25 | $10.5M | $-36.0M | ||
| Q2 25 | — | $-40.7M | ||
| Q1 25 | $9.6M | $-48.4M | ||
| Q4 24 | $15.0M | — | ||
| Q3 24 | $14.7M | $-41.7M | ||
| Q2 24 | $18.5M | $-80.3M |
毛利率ETDZLAB
| Q1 26 | 59.4% | — | ||
| Q4 25 | 60.9% | 51.0% | ||
| Q3 25 | 61.4% | 59.5% | ||
| Q2 25 | 59.9% | 60.6% | ||
| Q1 25 | 61.2% | 63.6% | ||
| Q4 24 | 60.3% | 61.5% | ||
| Q3 24 | 60.8% | 64.1% | ||
| Q2 24 | 60.8% | 64.9% |
营业利润率ETDZLAB
| Q1 26 | 4.8% | — | ||
| Q4 25 | 9.5% | -54.6% | ||
| Q3 25 | 6.8% | -42.3% | ||
| Q2 25 | 9.5% | -50.3% | ||
| Q1 25 | 7.7% | -53.3% | ||
| Q4 24 | 11.5% | -62.6% | ||
| Q3 24 | 11.4% | -66.6% | ||
| Q2 24 | 13.4% | -76.0% |
净利率ETDZLAB
| Q1 26 | 4.4% | — | ||
| Q4 25 | 7.8% | — | ||
| Q3 25 | 7.1% | -31.2% | ||
| Q2 25 | — | -37.3% | ||
| Q1 25 | 6.7% | -45.8% | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 9.5% | -40.9% | ||
| Q2 24 | 11.0% | -80.2% |
每股收益（稀释后）ETDZLAB
| Q1 26 | $0.23 | — | ||
| Q4 25 | $0.46 | $-0.05 | ||
| Q3 25 | $0.41 | $-0.03 | ||
| Q2 25 | $0.48 | $-0.04 | ||
| Q1 25 | $0.37 | $-0.04 | ||
| Q4 24 | $0.59 | $-0.09 | ||
| Q3 24 | $0.57 | $-0.04 | ||
| Q2 24 | $0.73 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.6M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $473.7M | $715.5M |
| 总资产 | $723.3M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ETDZLAB
| Q1 26 | $66.6M | — | ||
| Q4 25 | $139.3M | $689.6M | ||
| Q3 25 | $123.6M | $717.2M | ||
| Q2 25 | $136.1M | $732.2M | ||
| Q1 25 | $172.9M | $757.3M | ||
| Q4 24 | $139.1M | $779.7M | ||
| Q3 24 | $135.9M | $616.1M | ||
| Q2 24 | $161.0M | $630.0M |
股东权益ETDZLAB
| Q1 26 | $473.7M | — | ||
| Q4 25 | $478.2M | $715.5M | ||
| Q3 25 | $475.5M | $759.9M | ||
| Q2 25 | $482.4M | $791.7M | ||
| Q1 25 | $479.2M | $810.8M | ||
| Q4 24 | $478.8M | $840.9M | ||
| Q3 24 | $474.7M | $667.7M | ||
| Q2 24 | $483.0M | $704.2M |
总资产ETDZLAB
| Q1 26 | $723.3M | — | ||
| Q4 25 | $714.8M | $1.2B | ||
| Q3 25 | $737.1M | $1.2B | ||
| Q2 25 | $737.1M | $1.2B | ||
| Q1 25 | $738.7M | $1.2B | ||
| Q4 24 | $732.6M | $1.2B | ||
| Q3 24 | $737.7M | $985.3M | ||
| Q2 24 | $744.9M | $987.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流ETDZLAB
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $-26.0M | ||
| Q3 25 | $16.8M | $-32.0M | ||
| Q2 25 | $24.8M | $-31.0M | ||
| Q1 25 | $10.2M | $-61.7M | ||
| Q4 24 | $11.6M | $-55.8M | ||
| Q3 24 | $15.1M | $-26.8M | ||
| Q2 24 | $26.2M | $-42.2M |
自由现金流ETDZLAB
| Q1 26 | — | — | ||
| Q4 25 | $-4.7M | $-26.7M | ||
| Q3 25 | $14.4M | $-35.0M | ||
| Q2 25 | $22.9M | $-33.9M | ||
| Q1 25 | $8.2M | $-63.2M | ||
| Q4 24 | $7.8M | $-58.4M | ||
| Q3 24 | $11.5M | $-28.2M | ||
| Q2 24 | $24.2M | $-42.9M |
自由现金流率ETDZLAB
| Q1 26 | — | — | ||
| Q4 25 | -3.2% | -21.0% | ||
| Q3 25 | 9.8% | -30.4% | ||
| Q2 25 | 14.3% | -31.1% | ||
| Q1 25 | 5.7% | -59.9% | ||
| Q4 24 | 5.0% | -53.8% | ||
| Q3 24 | 7.4% | -27.7% | ||
| Q2 24 | 14.3% | -42.9% |
资本支出强度ETDZLAB
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 0.5% | ||
| Q3 25 | 1.6% | 2.6% | ||
| Q2 25 | 1.2% | 2.6% | ||
| Q1 25 | 1.4% | 1.5% | ||
| Q4 24 | 2.4% | 2.4% | ||
| Q3 24 | 2.3% | 1.3% | ||
| Q2 24 | 1.2% | 0.7% |
现金转化率ETDZLAB
| Q1 26 | — | — | ||
| Q4 25 | -0.16× | — | ||
| Q3 25 | 1.61× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 0.77× | — | ||
| Q3 24 | 1.02× | — | ||
| Q2 24 | 1.42× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ETD
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
